Highest-materiality recent filing
Enact Q2 2026 net income $175M ($1.25 EPS); raises full-year capital return guidance to $550-600M
GAAP net income $175M ($1.25 diluted EPS); adjusted operating income $177M ($1.26 diluted EPS).
Enact Q1 net income $168M, EPS $1.18; NIW up 30% YoY; dividend raised 14% to $0.24
GAAP net income $168M ($1.18/dil); adjusted operating income $172M ($1.21/dil).
Enact Q4 net income $177M, EPS $1.22; new $500M buyback program and $0.21 quarterly dividend
Q4 2025 net income $177M ($1.22 diluted EPS); adjusted operating income $179M ($1.23 diluted EPS).
Enact Holdings Q3 net income $163M ($1.10/sh), raises 2025 capital return target to ~$500M
GAAP net income $163M ($1.10/sh) vs $181M ($1.15/sh) YoY; adjusted operating income $166M ($1.12/sh).
Enact Q2 net income $168M ($1.11 EPS); raises 2025 capital return guidance to ~$400M
GAAP net income $168M ($1.11 diluted EPS) vs $184M ($1.16) a year ago; adjusted operating income $174M ($1.15).
Enact Q1 net income $166M ($1.08 EPS); dividend raised 14% to $0.21; new $350M buyback
GAAP net income $166M ($1.08 diluted EPS); adjusted operating income $169M ($1.10 diluted EPS).
Enact reports Q4 net income $163M ($1.05 EPS); declares $0.185 quarterly dividend
GAAP net income $163M ($1.05/share); adjusted operating income $169M ($1.09/share) for Q4 2024.
Enact Q3 net income $181M, $1.15 EPS; record IIF $268B; announces $0.185 dividend
GAAP net income $181M ($1.15 diluted), vs $184M ($1.16) in Q2 2024 and $164M ($1.02) in Q3 2023.
Net income $184M, up 10% vs Q2 2023; diluted EPS $1.16 vs $1.04 YoY.
Enact Holdings issues $750M of 6.250% Senior Notes due 2029, to redeem $750M of 2025 notes
Issued $750M of 6.250% Senior Notes due 2029 under an underwriting agreement with J.P. Morgan, Citigroup, Goldman Sachs.
Enact Q1 net income $161M ($1.01 EPS); board authorizes $250M buyback and 16% dividend hike
Q1 net income $161M ($1.01 diluted EPS); adjusted operating income $166M ($1.04).
Enact Q4 GAAP EPS $0.98, full year $4.11; record IIF $263B; returns >$300M to shareholders
Net income $157M ($0.98/sh) in Q4 vs $164M Q3; full year $666M ($4.11/sh). Adjusted operating income $158M ($0.98/sh).
Enact Q3 net income $164M ($1.02/sh); declares $0.71 special dividend
Net income $164M, diluted EPS $1.02; adjusted operating income also $164M ($1.02).
Enact Q2 GAAP EPS $1.04, adj EPS $1.10; record $258B IIF; ups 2023 capital return to $300M
GAAP net income $168M ($1.04/diluted); adjusted operating income $178M ($1.10/diluted).
Enact Q1 net income $176M ($1.08 EPS); record IIF $253B; dividend raised to $0.16
GAAP net income $176M ($1.08 diluted EPS) vs $144M prior quarter and $165M prior year; adjusted operating income $176M.
Q4 GAAP net income $144M ($0.88 diluted EPS); full year $704M ($4.31); adjusted operating income $147M ($0.90).
Enact Holdings declares special $1.12 dividend and $75M buyback
Special cash dividend of $183M ($1.12 per share) payable Dec 6, 2022; record Nov 18, 2022.
Enact Q3 net income $191M ($1.17/sh), declares special dividend $1.12/sh and $75M buyback
GAAP net income $191M ($1.17 diluted EPS) vs $205M in Q2 and $137M in Q3 2021.
Enact Q2 GAAP net income $205M, EPS $1.25; ROE 20.1%
Net income $205M ($1.25 diluted EPS) vs $165M ($1.01) Q1 and $131M ($0.80) Q2 2021.
Enact Q1 net income $165M ($1.01 EPS); initiates $0.14 quarterly dividend
GAAP net income $165M, $1.01 diluted EPS; adjusted operating income $165M, $1.01 diluted EPS.
Enact initiates quarterly dividend program, declares $0.14/sh inaugural dividend
Board approved a quarterly cash dividend program; inaugural Q2 2022 dividend of $0.14 per share.
Enact Q4 GAAP net income $154M ($0.94/sh); full year $547M ($3.36); $200M special dividend
Q4 GAAP net income $154M ($0.94 diluted EPS); full year $547M ($3.36 diluted).
Enact Holdings declares special cash dividend of $1.23 per share ($200M total)
Special cash dividend of $200 million, or $1.23 per share, declared by Board of Directors.
Enact Q3 GAAP net income $137M, EPS $0.84; PMIERs sufficiency record 181%
GAAP net income $137M ($0.84 diluted EPS); adjusted net operating income $137M ($0.84 diluted EPS).
On March 7, 2025, Anne G. Waleski advised Enact Holdings, Inc. (the “Company”) and the Company’s Board of Directors (the “Board”) of her intention not to stand for re-election as a director of the Company when her term expires at the Company’s upcoming 2025 Annual Meeting of Stockholders on May 14, 2025.
On March 11, 2025, the Board of Directors (the “Board”) of Enact Holdings, Inc., a Delaware Corporation (the “Corporation” or “Enact”), appointed H. Elizabeth Mitchell to serve as a director for a term expiring at the 2025 Annual Meeting of Stockholders.
On March 1, 2023, the Board of Directors (the “Board”) of Enact Holdings, Inc., a Delaware Corporation (the “Corporation” or “Enact”), appointed Jerome T. Upton to serve as a Director for a term expiring at the 2023 Annual Meeting of Stockholders.
On February 5, 2023, Daniel J. Sheehan IV advised Enact Holdings, Inc. (the “Company”) and the Company’s Board of Directors (the “Board”) of his intention to resign from the Board effective March 1, 2023.
On March 9, 2022, the Board of Directors (the “Board”) of Enact Holdings, Inc., a Delaware Corporation (the “Corporation” or “Enact”), appointed Michael Bless to serve as a Director for a term expiring at the 2022 Annual Meeting of Stockholders.
Max materiality 0.85 · Median 0.68 · Most common event earnings